ICICI Direct has buy call on with a target price of Rs 675. The current market price of . is Rs 496.45.

Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 26800.80 Crore) operating in Pharmaceuticals sector.

Laurus Labs Ltd. key Products/Revenue Segments include Pharmaceutical Products, Traded Goods, Contract Service, Other Operating Revenue, Scrap for the year ending 31-Mar-2022.


For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 1540.69 Crore, up 8.03 % from last quarter Total Income of Rs 1426.12 Crore and up 19.96 % from last year same quarter Total Income of Rs 1284.35 Crore. Company reported net profit after tax of Rs 252.54 Crore in latest quarter.

Promoter/FII Holdings
Promoters held 27.27 per cent stake in the company as of 30-Jun-2022, while FIIs owned 26.0 per cent, DIIs 5.09 per cent.

(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.


Source link

By Dipak

Leave a Reply

Your email address will not be published. Required fields are marked *